Krystal Biotech, Inc is a biotechnology business based in the US. Krystal Biotech shares (KRYS) are listed on the NASDAQ and all prices are listed in US Dollars. Krystal Biotech employs 75 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Krystal Biotech
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – KRYS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Krystal Biotech stock price (NASDAQ: KRYS)Use our graph to track the performance of KRYS stocks over time.
Krystal Biotech shares at a glance
|Latest market close||$65.24|
|52-week range||$39.39 - $87.29|
|50-day moving average||$65.11|
|200-day moving average||$70.62|
|Wall St. target price||$100.78|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.20|
Buy Krystal Biotech shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Krystal Biotech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Krystal Biotech price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||-6.80%|
|3 months (2021-05-03)||-15.27%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Krystal Biotech financials
|Gross profit TTM||$0|
|Return on assets TTM||-7.99%|
|Return on equity TTM||-13.56%|
|Market capitalisation||$1.3 billion|
TTM: trailing 12 months
Shorting Krystal Biotech shares
There are currently 1.1 million Krystal Biotech shares held short by investors – that's known as Krystal Biotech's "short interest". This figure is 1.4% down from 1.1 million last month.
There are a few different ways that this level of interest in shorting Krystal Biotech shares can be evaluated.
Krystal Biotech's "short interest ratio" (SIR)
Krystal Biotech's "short interest ratio" (SIR) is the quantity of Krystal Biotech shares currently shorted divided by the average quantity of Krystal Biotech shares traded daily (recently around 148081.28415301). Krystal Biotech's SIR currently stands at 7.32. In other words for every 100,000 Krystal Biotech shares traded daily on the market, roughly 7320 shares are currently held short.
However Krystal Biotech's short interest can also be evaluated against the total number of Krystal Biotech shares, or, against the total number of tradable Krystal Biotech shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Krystal Biotech's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Krystal Biotech shares in existence, roughly 50 shares are currently held short) or 0.0716% of the tradable shares (for every 100,000 tradable Krystal Biotech shares, roughly 72 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Krystal Biotech.
Find out more about how you can short Krystal Biotech stock.
Krystal Biotech share dividends
We're not expecting Krystal Biotech to pay a dividend over the next 12 months.
Krystal Biotech share price volatility
Over the last 12 months, Krystal Biotech's shares have ranged in value from as little as $39.393 up to $87.287. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Krystal Biotech's is 1.1324. This would suggest that Krystal Biotech's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Krystal Biotech overview
Krystal Biotech, Inc. , a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and acne scars; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx for other rare lung disease. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Stocks similar to Krystal Biotech
Krystal Biotech in the news
Fly Intel: Top five analyst upgrades
Krystal Biotech upgraded to Buy from Neutral at Goldman Sachs
Krystal Biotech Breaks Below 200-Day Moving Average - Notable for KRYS
Frequently asked questionsWhat percentage of Krystal Biotech is owned by insiders or institutions?
Currently 24.595% of Krystal Biotech shares are held by insiders and 75.197% by institutions. How many people work for Krystal Biotech?
Latest data suggests 75 work at Krystal Biotech. When does the fiscal year end for Krystal Biotech?
Krystal Biotech's fiscal year ends in December. Where is Krystal Biotech based?
Krystal Biotech's address is: 2100 Wharton Street, Pittsburgh, PA, United States, 15203 What is Krystal Biotech's ISIN number?
Krystal Biotech's international securities identification number is: US5011471027 What is Krystal Biotech's CUSIP number?
Krystal Biotech's Committee on Uniform Securities Identification Procedures number is: 501147102
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert